Back to search
FDAFDA · Food and drugs·Recall number D-164-2013

Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.

Published February 20, 2013 · Recall initiated: January 7, 2013

Summary

FDA records drug Class III recall D-164-2013, published February 20, 2013 and initiated January 7, 2013. Recalling firm: West-ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 1,185 Bottles; Lot: Lot #: 69001A. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
West-ward Pharmaceutical Corp.
Distributor
OH
Lot
Lot #: 69001A
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01. recalled?

Yes. FDA published recall D-164-2013 on February 20, 2013. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter